Sangamo stockholders approve 14M share increase to 2018 equity plan

SANGAMO THERAPEUTICS, INC

Share reserve increased by 14,000,000 shares; total now includes 8.8M, 9.9M, 7.9M, 10M, 11M from prior years.
Incentive stock option limit raised to 123,200,000 shares.
All nine director nominees elected, including Courtney Beers, Kenneth Hillan, and H. Stewart Parker.
Advisory say-on-pay approved: 32.8M for, 23.2M against, 1.3M abstentions.
Ratification of Ernst & Young as independent auditor for FY2025 passed with 119.6M for.

item 5.02item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.